SBI Securities’s Entera Bio ENTX Stock Holding History

SBI Securities’s Portfolio ENTX Stock Details ENTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2	Closed	-$2	–	4108
2026 Q1	$2	Buy	+2	New	+$3	﹤0.01%	3960
2025 Q4	–	Sell	-1	Closed	-$2	–	4091
2025 Q3	$2	Buy	+1	New	+$2	﹤0.01%	4145

Other funds holding ENTX

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

SEIA

Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $163M AUM

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

SBI Securities's ENTX Position: Q2 2026 in Review

SBI Securities sold out of Entera Bio (ENTX) in Q2 2026, closing a stake of 2 shares — an estimated $2 sold.

SBI Securities first reported a position in ENTX in Q3 2025 and held it in 2 quarters. The position peaked at $2 in Q1 2026. 15 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

SBI Securities reported no remaining Entera Bio position as of Q2 2026 after selling out during the quarter.
SBI Securities sold 2 Entera Bio shares in Q2 2026, an estimated $2.
SBI Securities first reported a position in Entera Bio in Q3 2025 and held it in 2 quarters.
SBI Securities's Entera Bio position peaked at $2 in Q1 2026.
15 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.